Is AVEFF or SBUX a better dividend investment in 2026?

AVEFF currently yields 44444.44% with a 5% 5-year dividend growth rate. SBUX yields 2.84% with 5% growth. The better choice depends on your goal: AVEFF offers higher current income.

What is the dividend yield difference between AVEFF and SBUX?

AVEFF has a forward dividend yield of 44444.44% ($2.00/share annually). SBUX yields 2.84% ($2.46/share annually). The yield gap is 44441.60 percentage points.

Home › Compare › AVEFF vs SBUX

AVEFF vs SBUX: Dividend Comparison 2026

AVEFF yields 44444.44% · SBUX yields 2.84%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AVEFF wins by $1.4802188700273396e+23M in total portfolio value

INVESTMENT

TIME HORIZON10 years

AVEFF

● Live price

44444.44%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.4802188700273396e+23M

Annual income

$147,369,615,738,581,320,000,000,000,000.00

Full AVEFF calculator →

SBUX

● Live price

2.84%

Share price

$86.72

Annual div

$2.46

5Y div CAGR

48.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$167.0K

Annual income

$71,136.45

Full SBUX calculator →

Portfolio growth — AVEFF vs SBUX

📍 AVEFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AVEFF	SBUX
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AVEFF + SBUX cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AVEFF pays

SBUX pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVEFF

Annual income on $10K today (after 15% tax)

$3,777,777.78/yr

After 10yr DRIP, annual income (after tax)

$125,264,173,377,794,110,000,000,000,000.00/yr

SBUX

Annual income on $10K today (after 15% tax)

$241.12/yr

After 10yr DRIP, annual income (after tax)

$60,465.98/yr

At 15% tax rate, AVEFF beats the other by $125,264,173,377,794,110,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVEFF + SBUX for your $10,000?

AVEFF: 50%SBUX: 50%

100% SBUX50/50100% AVEFF

Portfolio after 10yr

$7.401094350136698e+22M

Annual income

$73,684,807,869,290,660,000,000,000,000.00/yr

Blended yield

99.56%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

AVEFF

No analyst data

Altman Z

-49.2

Piotroski

4/9

SBUX

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$104.00

+19.9% upside vs current

Range: $90.00 — $120.00

Altman Z

2.6

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVEFF buys

SBUX buys

No recent congressional trades found for AVEFF or SBUX in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAVEFFSBUX

Forward yield	44444.44% ✓	2.84%
Annual dividend / share	$2.00	$2.46 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	48.3% ✓
Portfolio after 10y	$1.4802188700273396e+23M	$167.0K ✓
Annual income after 10y	$147,369,615,738,581,320,000,000,000,000.00 ✓	$71,136.45
Total dividends collected	$1.4797905017086652e+23M	$136.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Discretionary

Year-by-year: AVEFF vs SBUX ($10,000, DRIP)

Year	AVEFF Portfolio	AVEFF Income/yr	SBUX Portfolio	SBUX Income/yr	Gap
1← crossover	$4,455,144	$4,444,444.44	$11,121	$420.68	+$4.44M → AVEFF
2	$1,855,294,292	$1,850,527,287.41	$12,548	$648.40	+$1855.28M → AVEFF
3	$722,201,114,647	$720,215,949,754.98	$14,440	$1,013.98	+$722201.10M → AVEFF
4	$262,786,638,114,837	$262,013,882,922,164.10	$17,068	$1,617.30	+$262786638.10M → AVEFF
5	$89,382,811,928,504,960	$89,101,630,225,722,080.00	$20,912	$2,649.52	+$89382811928.48M → AVEFF
6	$28,419,510,536,946,614,000	$28,323,870,928,183,110,000.00	$26,875	$4,499.29	+$28419510536946.59M → AVEFF
7	$8,446,906,587,814,894,000,000	$8,416,497,711,540,360,000,000.00	$36,771	$8,014.12	+$8446906587814894.00M → AVEFF
8	$2,346,953,255,508,951,600,000,000	$2,337,915,065,459,989,300,000,000.00	$54,542	$15,197.11	+$2346953255508951552.00M → AVEFF
9	$609,599,312,292,179,560,000,000,000	$607,088,072,308,785,000,000,000,000.00	$89,602	$31,242.49	+$609599312292179607552.00M → AVEFF
10	$148,021,887,002,733,950,000,000,000,000	$147,369,615,738,581,320,000,000,000,000.00	$167,011	$71,136.45	+$1.4802188700273396e+23M → AVEFF

AVEFF vs SBUX: Complete Analysis 2026

AVEFF — Stock

Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It also provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney to conduct a study to examine whether topically applied cannabidiol can provide relief from symptoms of osteoarthritis. It serves customers in Australia, Switzerland, India, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.

Full AVEFF Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →

📬

Get this AVEFF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVEFF vs SCHD AVEFF vs JEPI AVEFF vs O AVEFF vs KO AVEFF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.